Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects - PubMed (original) (raw)
Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects
O G Kolterman et al. J Clin Invest. 1980 Jun.
Abstract
To assess the mechanisms of the insulin resistance in human obesity, we have determined, using a modification of the euglycemic glucose clamp technique, the shape of the in vivo insulin-glucose disposal dose-response curves in 7 control and 13 obese human subjects. Each subject had at least three euglycemic studies performed at insulin infusion rates of 15, 40, 120, 240, or 1,200 mU/M2/min. The glucose disposal rate was decreased in all obese subjects compared with controls (101 +/- 16 vs. 186 +/- 16 mg/M2/min) during the 40 mU/M2/min insulin infusion. The mean dose-response curve for the obese subjects was displaced to the right, i.e., the half-maximally effective insulin concentration was 270 +/- 27 microU/ml for the obese compared with 130 +/- 10 microU/ml for controls. In nine of the obese subjects, the dose-response curves were shifted to the right, and maximal glucose disposal rates (at a maximally effective insulin concentration) were markedly decreased, indicating both a receptor and a postreceptor defect. On the other hand, four obese patients had right-shifted dose-response curves but reached normal maximal glucose disposal rates, consistent with decreased insulin receptors as the only abnormality. When the individual data were analyzed, it was found that the lease hyperinsulinemic, least insulin-resistant patients displayed only the receptor defect, whereas those with the greatest hyperinsulinemia exhibited the largest post-receptor defect, suggesting a continuous spectrum of defects as one advances from mild to severe insulin resistance. When insulin's ability to suppress hepatic glucose output was assessed, hyperinsulinemia produced total suppresssion in all subjects. The dose-response curve for the obese subjects was shifted to the right, indicating a defect in insulin receptors. Insulin binding to isolated adipocytes obtained from the obese subjects was decreased, and a highly significant inverse linear relationship was demonstrated between insulin binding and the serum insulin concentration required for halfmaximal stimulation of glucose disposal.
In conclusion: (a) decreased cellular insulin receptors contribute to the insulin resistance associated with human obesity in all subjects; (b) in the least hyperinsulinemic, insulin-resistant patients, decreased insulin receptors are the sole defect, whereas in the more hyperinsulinemic, insulin-resistant patients, the insulin resistance is the result of a combination of receptor and postreceptor abnormalities; (c) all obese patients were insensitive to insulin's suppressive effects on hepatic glucose output; this was entirely the result of decreased insulin receptors; no postreceptor defect in this insulin effect was demonstrated.
Similar articles
- Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.
Kolterman OG, Gray RS, Griffin J, Burstein P, Insel J, Scarlett JA, Olefsky JM. Kolterman OG, et al. J Clin Invest. 1981 Oct;68(4):957-69. doi: 10.1172/jci110350. J Clin Invest. 1981. PMID: 7287908 Free PMC article. - Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
Revers RR, Fink R, Griffin J, Olefsky JM, Kolterman OG. Revers RR, et al. J Clin Invest. 1984 Mar;73(3):664-72. doi: 10.1172/JCI111258. J Clin Invest. 1984. PMID: 6368585 Free PMC article. - Mechanisms of insulin resistance in aging.
Fink RI, Kolterman OG, Griffin J, Olefsky JM. Fink RI, et al. J Clin Invest. 1983 Jun;71(6):1523-35. doi: 10.1172/jci110908. J Clin Invest. 1983. PMID: 6345584 Free PMC article. - The impact of sulfonylurea treatment upon the mechanisms responsible for the insulin resistance in type II diabetes.
Kolterman OG, Olefsky JM. Kolterman OG, et al. Diabetes Care. 1984 May-Jun;7 Suppl 1:81-8. Diabetes Care. 1984. PMID: 6376033 Review. - Insulin receptors and action in clinical disorders of carbohydrate tolerance.
Pollet RJ. Pollet RJ. Am J Med. 1983 Nov 30;75(5B):15-22. doi: 10.1016/0002-9343(83)90249-8. Am J Med. 1983. PMID: 6369964 Review.
Cited by
- Association of triglyceride-glucose index and delirium in patients with sepsis: a retrospective study.
Fang Y, Dou A, Shen Y, Li T, Liu H, Cui Y, Xie K. Fang Y, et al. Lipids Health Dis. 2024 Jul 25;23(1):227. doi: 10.1186/s12944-024-02213-x. Lipids Health Dis. 2024. PMID: 39054513 Free PMC article. - Role of Dietary Macronutrient Composition and Fibre Intake in Development of Double Diabetes in Indian Youth.
Oza C, Mandlik R, Khadilkar AV, Gondhalekar KM, Khadilkar VV. Oza C, et al. Indian J Endocrinol Metab. 2024 Mar-Apr;28(2):213-219. doi: 10.4103/ijem.ijem_90_23. Epub 2024 Apr 29. Indian J Endocrinol Metab. 2024. PMID: 38911111 Free PMC article. - Determinants and Characteristics of Insulin Dose Requirements in Children and Adolescents with New-Onset Type 1 Diabetes: Insights from the INSENODIAB Study.
Beckers M, Polle O, Gallo P, Bernard N, Bugli C, Lysy PA. Beckers M, et al. J Diabetes Res. 2023 Nov 26;2023:5568663. doi: 10.1155/2023/5568663. eCollection 2023. J Diabetes Res. 2023. PMID: 38846373 Free PMC article. - Long-term survival in stroke patients: insights into triglyceride-glucose body mass index from ICU data.
Huang Y, Li Z, Yin X. Huang Y, et al. Cardiovasc Diabetol. 2024 Apr 25;23(1):137. doi: 10.1186/s12933-024-02231-0. Cardiovasc Diabetol. 2024. PMID: 38664780 Free PMC article.
References
- Proc Natl Acad Sci U S A. 1977 Jan;74(1):348-52 - PubMed
- Fed Proc. 1977 Feb;36(2):229-35 - PubMed
- Endocrinology. 1968 Jun;82(6):1133-41 - PubMed
- Diabetes. 1974 Jul;23(7):565-71 - PubMed
- N Engl J Med. 1967 Feb 9;276(6):314-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials